The Litwin-Zucker Research Center is an initiative of the North Shore-Long Island Jewish Health System, with a focus on developing cutting-edge research in the area of Alzheimer's disease. The Center was established in 2004 through the generosity and vision of Leonard Litwin and Donald & Barbara Zucker. The research program at the center is focused on understanding the basic biology of Alzheimer's disease, and creating and testing strategies for treatment and prevention for the disease. Over 5 million people in the United States currently have Alzheimer's disease, and the number of affected individuals is expected to climb to 11-16 million by 2050, as a result of the aging population and increased life expectancy. This increase represents a serious public health problem with dramatic financial implications.

In addition to public health concerns, the impact on individual families facing the disease is multifaceted with serious physical, emotional and financial repercussions. The mission of the Litwin-Zucker Center is to develop cutting-edge research in the area of Alzheimer's disease and memory disorders and to bring that research to the patients and families that are struggling with these debilitating illnesses. Our goal is to continue to expand our programs to include research in the area of prevention, treatment, imaging, and genetics of Alzheimer's disease and other memory disorders of aging.